Industry Should Prioritize “Process Of Trust” With Consumers – Cosmetics Europe
This article was originally published in The Rose Sheet
Executive Summary
Industry must keep consumers at the forefront of its decisions as it grapples with regulatory issues regarding fragrance allergen labeling, preservatives and nanotechnology, Cosmetics Europe Director-General Bertil Heerink suggested in an interview with “The Rose Sheet.” Remaining mindful of consumer needs and perceptions will help drive public trust in the cosmetics industry, which is one of the biggest challenges the sector faces, he said.
You may also be interested in...
Cosmetics Europe Seeks Director-General With Heerink Gone
Brussels-based trade group’s activities “continue as usual,” headed by President Loic Armand and Interim Deputy Director-General Gerd Ries following the departure of Bertil Heerink, a spokesperson for the organization told “The Rose Sheet,” declining to offer further detail. Heerink held the position for just shy of 12 years prior to his exit.
IFRA Offers EU Parliament A ‘Sense Of Reality’ On Fragrance Issues
Members of the European Parliament, the European Commission and the fragrance industry are making headway in efforts to achieve consensus regarding sensitive fragrance issues and the development of “effective” legislation that promotes consumer confidence along with competition. IFRA’s recent “Sense of Reality” exhibition at the European Parliament in Brussels highlighted the art and science of fragrance creation as well as the importance of trade secrets in the sector.
Attn. Europe: CIR Identifies Safe Limit For Preservative MI In Leave-Ons
CIR’s Expert Panel recommends a limit of 4 ppm for preservative methylisothiazolinone in leave-on cosmetic products and 100 ppm in rinse-off formulas at a June 9-10 meeting in Washington, drawing from QRA data supplied by Cosmetics Europe. While CIR is still reviewing the Quantitative Risk Assessment for MI in various product categories, the panel decided to issue an assessment now, as the regulatory fate of the ingredient hangs in the balance in the EU.